IDXX - Company ID 0000874716
IDEXX LABORATORIES INC /DE (IDXX) reported revenue of $4.30B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $4.30B | +10.4% |
| FY 2024 | $3.90B | +6.5% |
| FY 2023 | $3.66B | +8.7% |
| FY 2022 | $3.37B | +4.7% |
| FY 2021 | $3.22B | +18.8% |
| FY 2020 | $2.71B | +12.5% |
| FY 2019 | $2.41B | +8.8% |
| FY 2018 | $2.21B | +12.4% |
| FY 2017 |
IDEXX LABORATORIES INC /DE (IDXX) reported revenue of $4.30B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, IDEXX LABORATORIES INC /DE's revenue grew from $1.22B to $4.30B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.97B |
| +10.9% |
| FY 2016 | $1.78B | +10.8% |
| FY 2015 | $1.60B | +7.8% |
| FY 2014 | $1.49B | +7.9% |
| FY 2013 | $1.38B | +6.5% |
| FY 2012 | $1.29B | +6.1% |
| FY 2011 | $1.22B | - |